MHAT - Silistra AD
Silistra, Bulgaria
Hospital in Silistra
ul. "Petar Mutafchiev" 80, 7500 Silistra Center, Silistra
About MHAT - Silistra AD
"Диагностика и лечение на заболявания Родилна помощ; Рехабилитация; Диагностика и консултации, поискани от лекар или лекар по дентална медицина от други лечебни заведения ; Вземане и експертиза на органи (откриване, установяване на мозъчна смърт и поддържане на жизнените функции на потенциален донор с мозъчна смърт при налична сърдечна дейност) и предоставяне им за трансплантация; Вземане, съхранявана, снабдяване с кръв и кръвни съставки, трансфузионен надзор; Диспансеризация; Клинични изпитания на лекарствени продукти и медицински изделия Учебна и научна дейност"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at MHAT - Silistra AD
During the past decade, MHAT - Silistra AD conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on
average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Cluster Randomized Trial of Hospitals to Assess Impact of Targeted Versus Universal Strategies to Reduce Methicillin-resistant Staphylococcus Aureus (MRSA) in Intensive Care Units (ICUs)
2009-09-01
2011-09-01
Completed
74,256
Registry Experience at the Washington Hospital Center, Des - Taxus Liberte Versus Xience V
2010-06-01
2010-09-01
Completed
1,200
Rib Fixation for Clinically Severe Rib Fractures From Trauma
2015-04-01
2023-12-01
Recruiting
236
Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry
2016-04-26
2023-12-01
Active, not recruiting
271
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at MHAT - Silistra AD
According to Clinical.Site data, the most researched conditions in "MHAT - Silistra AD" are
"Colitis, Ulcerative" (2 trials), "Clostridium Difficile Infection" (1 trials), "Crohn's Disease" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "MHAT - Silistra AD" in a lesser frequency.
Clinical Trials Intervention Types at MHAT - Silistra AD
Most popular intervention types in "MHAT - Silistra AD" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Clostridium difficile vaccine" (1 trials), "GED-0507-34-Levo 160 mg" (1 trials), "GED-0507-34-Levo 80 mg" (1 trials) and "Placebo IV" (1 trials). Other intervention names were less common.
Clinical Trials Genders at MHAT - Silistra AD
The vast majority of trials in "MHAT - Silistra AD" are
4 trials for "All" genders.
Clinical Trials Status at MHAT - Silistra AD
Currently, there are NaN active trials in "MHAT - Silistra AD".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in MHAT - Silistra AD,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in MHAT - Silistra AD, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".